AARP on its latest drug price campaign: ‘There’s a lot of anger out there’
The organization has fighting words for Big Pharma.
Advertising
Sex, drugs and off-label advertising
Online prescription startups are operating in a legal gray zone of medical marketing. Could this be the next demonstration case for FDA ad police?
Accenture Interactive buys Droga5, consultancy confirms
The iconic agency will build out the juggernaut’s experience offering.
The voices behind pharma DTC ads bring art to science
Big words and warnings. Not much time. The voices behind pharma ads bring art to science.
Eli Lilly, Johnson & Johnson take initiative, get in front of PhRMA guidelines
Eli Lilly and Johnson & Johnson take the lead on PhRMA’s new guidelines for DTC ads.
Nielsen: Pfizer tops list of biggest pharma advertisers in 2018
The industry spent $6.4 billion on advertising last year, with the bulk going to TV spots.
Expect legislative baby steps, not big leaps on drug prices
Even though both parties agree on lowering drug prices, experts predict changes will be incremental.
Publicis shares crash 12% after creative agencies slump
WPP, Interpublic, and Omnicom also saw stocks slide.
Clarity in DTC TV ad drug pricing
Belle Frank is chief strategy officer, global health practice at VMLY&R.
Will increased scrutiny on digital advertising help drive innovation in healthcare marketing?
Traditional digital advertising needs some shaking up, and increased scrutiny just may be the impetus to make that happen, says Lou Iovino, president of Calcium, in this next edition of Outlook 2019, MM&M’s sponsored video series.
